7 Responses

  1. Kate Mooreson
    Kate Mooreson November 27, 2012 at 9:38 am | | Reply

    Diabetes is such a delicate disease such that its treatment would require a great deal of trials and testing. The disease has been around for quite a while and knowing what is involved in drug and treatment R&D, the ultimate goal of treatment is not expected to be met in a twinkle of an eye.

    I think we all should be thankful at the positive out come of DIABECELL and the achievements of Living Cell Technologies (LCT) hoping that in the nearest future, the ultimate treatment goal which is complete cure will be reached.

    In the meantime; to good health!!

  2. guru
    guru November 30, 2012 at 8:50 am | | Reply

    Really useful information for diabetic patients. There should some non-surgical cure for diabetes. I hope,in medical advancement we will achive it in future.

  3. walaa bahnas
    walaa bahnas December 14, 2012 at 5:40 pm | | Reply

    i hope one day i kann live without insulin

  4. Al Steiner
    Al Steiner March 15, 2013 at 9:26 am | | Reply

    Xenotransplantation is the transplantation of living cells from one species to another. This technology is commonly used in a preclinical setting to test the efficacy of human cancer treatments within model organisms such as rats and mice. The information provided by such studies is then used to develop phase I trials in which an actual humans are the test subjects.
    With an increase in transplantation technology, has come a higher demand for organs and tissue. This demand has led to the xenotransplantation of animal organs, tissue and cells into suitable human patients.
    At Altogen Labs in vivo xenograft services are utilized to conduct drug development treatments to treat inflammation, infectious diseases, cancer, pain, immunology and obesity. As a GLP-compliant laboratory, animal handling is IACUC-regulated and in accordance with FDA regulations. A variety of disease models are also available for testing.

  5. ronald conklin
    ronald conklin May 30, 2013 at 4:53 pm | | Reply

    if you can cure 14 patients safely then take it away from the Phd’s and turn it over to marketing so we can cure millions. the eggheads will never be satisfied with their results. if you left it up to the eggheads all diabetics would die and they still would not be satisfied with the cure. i realize that a corrupt FDA who sleeps with big pharma is a problem. companies who have cures for diabetes, and there are several of them must move overseas and become humanitarian heros.

    1. Anonymous
      Anonymous October 19, 2014 at 3:08 am | | Reply

      These test are also to try and stabilize the results and the test patients weren’t cured. Their conditions were made better for a period of over a year but to get the best results they need to do more tests to know the quantity of islet cells to transplant. Also the test to prove it’s safety will be a weapon to combat those who question the process. So don’t get all high and mighty about it, it is for the best. One last thing, LCT is a New Zealand Company and doesn’t have the huge pharmaceutical companies breathing down their necks anywhere near as much as American companies. The way they are doing it is for safety and to get the best results.

  6. ronald conklin
    ronald conklin June 2, 2013 at 6:28 am | | Reply

    it is absolutely disgusting. the FDA are in bed with big pharma. when big pharma says to the FDA, don’t approve of a cure for diabetes because it will hurt our insulin business, the FDA listenes. case in point. VIACYTE has had a cure since 2007 and now the FDA says it might approve clinical trials in 2015. this proves the FDA is as corrupt as the IRS.

Leave a Reply